FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

734570008: Sodium glucose cotransporter subtype 2 inhibitor (disposition)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3509180010 Sodium glucose cotransporter subtype 2 inhibitor (disposition) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3509181014 Sodium glucose cotransporter subtype 2 inhibitor en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sodium glucose cotransporter subtype 2 inhibitor Is a Cellular transport inhibitor true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action Has disposition True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Existential restriction modifier
Dapagliflozin Has disposition True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Existential restriction modifier
Dapagliflozin propanediol Has disposition True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Existential restriction modifier
Canagliflozin Has disposition True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Existential restriction modifier
Empagliflozin Has disposition True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Existential restriction modifier
Canagliflozin hemihydrate Has disposition True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Existential restriction modifier
Ertugliflozin Has disposition True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Existential restriction modifier
Dapagliflozin propanediol monohydrate Has disposition True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Existential restriction modifier
Ertugliflozin pidolate Has disposition True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Existential restriction modifier
Remogliflozin etabonate Has disposition True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start